Comments Regarding Identification, Assessment, and Control of Nitrosamine Drug Substance-Related Impurities in Human Drug Products Share page: Docket Number: FDA-2023-N-1585-0001 Download Document Issues: OTC Medicines Other Issues Quality Related Posts CHPA Chat Our Issues Regulation of OTC Medicines